Increasing tinea capitis prevalence in Stockholm reflects immigration

References

• Wahlgren CF, Kaaman T, Wikstrom U. Exotic tinea. Increased occurrence among children in the district of Stockholm. La� kartidningen 1993; 90: 1761–1763.
   Google Scholar
• Gupta AK, Summerbell RC. Tinea capitis. Med Mycol 2000; 38: 255-287.
   Google Scholar
• Hay RJ, Robles W, Midgley G. Tinea capitis in Europe: new perspective on an old problem. JEADV 2001; 15: 229-233.
   Google Scholar
• Elewski BE. Tinea capitis: a current perspective. J Am Acad Dermatol 2000; 42: 1–20.
   Google Scholar
• De Hoog GS, Guarro J, Gene� J, Figueras MJ. Atlas of Clinical Fungi, 2nd edn. Utrecht, The Netherlands: Centraalbureau voor Schimmelkultures, 2000.
   Google Scholar
• Campbell CK, Johnson EM, Philpot CM, Warnock DW. The dermatophytes. In: Campbell CK, Johnson EM, Philpot CM, Warnock DW (eds). Identification of Pathogenic Fungi . London: Public Health Laboratory Service, 1996; 26–71.
   Google Scholar
• Lamb SR, Rademaker M. Tinea due to Trichophyton violaceum and Trichophyton soudanense in Hamilton, New Zealand. Australas J Dermatol 2001; 42: 260–263.
   Google Scholar
• Chen BK, Friedlander S. Tinea capitis update: a continuing conflict with an old adversary. Curr Opin Pediatr 2001; 13: 331–335.
   Google Scholar
• Lobato MN, Vugia J, Frieden IJ. Tinea capitis in California children: a population-based study of a growing epidemic. Pediatrics 1997; 99: 551–554.
   Google Scholar
• Figueroa JI, Hawranek T, Abraha A, Hay RJ. Tinea capitis in south-western Ethiopia: a study of risk factors for infection and carriage. Int J Dermatol 1997; 36: 661–666.
   Google Scholar
• Bergson CL, Conceicao F. Tinea capitis: study of asymptomatic carriers and sick adolescents, adults and elderly who live with children with the disease. Rev Inst Med Trop Sao Paulo 2001; 43: 87–91.
   Google Scholar
• Williams JV, Honig PJ,McGinley KJ, Leyden JJ. Semiquantitative study of tinea capitis and the asymptomatic carrier state in innercity school children. Pediatrics 1995; 96: 265–267.
   Google Scholar
• Clayton YM. Superficial fungal infections. In: Harper J, Oranje A, Prose N (eds). Textbook of Pediatric Dermatology, 1999: 447–460.
   Google Scholar
• Sharma V, Silverberg N, Howard R, Tran CT, Laude TA, Frieden IJ. Do hair care practices affect the acquisition of tinea capitis? Arch Pediatr Adolesc Med 2001; 155: 818–821.
   Google Scholar
• Mackenzie DWR. �Hairbrush diagnosis� in detection and eradication of non-fluorescent scalp ringworm. Br Med J 1963; ii: 363–365.
   Google Scholar
• Higgins EM, Fuller LC, Smith CH. Guidelines for the management of tinea capitis. Br J Dermatol 2000; 143: 53–58.
   Google Scholar
• Bonifazi E, Berloco A. Antimycotic treatment in children. Eur J Pediatr Dermatol 2000; 10: 33–37.
   Google Scholar
• Greer DL. Successful treatment of tinea capitis with 2% ketoconazole shampoo. Int J Dermatol 2000; 39: 302–304.
   Google Scholar
• Jones TC. Overview of the use of terbinafine (Lamisil) in children. Br J Dermatol 1995; 132: 683–689.
   Google Scholar
• Friedlander SF, Aly R, Krafchik B, et al . Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, doubleblind, parallel-group, duration-finding study. Pediatrics 2002; 109: 602–607.
   Google Scholar
• Krafchik B, Pelletier J. An open study of tinea capitis in 50 children treated with a 2-week course of oral terbinafine. J Am Acad Dermatol 1999; 41: 60–63.
   Google Scholar
• Bennett ML, Fleischer AB, Loveless JW, Feldman SR. Oral griseofulvin remains the treatment of choice for tinea capitis in children. Pediatr Dermatol 2000; 17: 304–309.
   Google Scholar
• Bruckbauer HR, Hofman H. Systemic antifungal treatment of children with terbinafine. Dermatology 1997; 195: 134–136.
   Google Scholar
• Koumantaki E, Kakourou T, Rallis E, Riga P, Georgalla. S. Doubled dose of oral terbinafine is required for Microsporum canis tinea capitis. Pediatr Dermatol 2001; 18: 339–342.
   Google Scholar
• Pomeranz AJ, Sabnis SS. Tinea capitis: epidemiology, diagnosis and management strategies. Paediatr Drugs 2002; 4(12): 779-83.
   Google Scholar